Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
215 1 |
Ultima descărcare din IBN: 2024-01-13 21:10 |
Căutarea după subiecte similare conform CZU |
616.24-002.5-053.2-036 (1) |
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (760) |
SM ISO690:2012 VERINGĂ, Ana. Aspects of the evolution of drugresistant tuberculosis in children. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2022, nr. 3 An.1(29), p. 234. ISSN 2345-1467. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Ştiinţe ale Sănătăţii din Moldova | ||||||
Numărul 3 An.1(29) / 2022 / ISSN 2345-1467 | ||||||
|
||||||
CZU: 616.24-002.5-053.2-036 | ||||||
Pag. 234-234 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Multidrug-resistant tuberculosis is a growing global health crisis that affects about 30,000 children worldwide each year. The Republic of Moldova is among the 30 countries with a high burden of multidrug-resistant tuberculosis. Objective of the study. Studying the peculiarities of the evolution of drug-resistant tuberculosis in children. Material and Methods. The study included the analysis of 30 cases of drug-resistant tuberculosis in children hospitalized for treatment at the Municipal Clinical Hospital of Phthisiopneumology in Chisinau in 2021, of which 1 patient was excluded from TB recurrence. 29 medical records were analyzed, of which 19 boys and 10 girls. Results. Age of children: 0-3 years – 9 (31%); 4-7 years – 5 (17.2%); 8-12 years – 7 (24.2%); 13-18 years – 8 (27.6%). Microbiologically confirmed – 6 (79.3%) cases. Clinical forms: intrathoracic lymph node TB –19 (65.5%), primary tuberculosis complex – 4 (13.8%), infiltrative pulmonary TB – 6 (20.7%). New case of TB DR – 26 (89.6%), recurrence – 3 (10.4%). 27 cases were actively detected (92.1%). Contact with TB patients DR – 25 cases (86.2%). Comorbidities: respiratory-5 (17.3%), gastrointestinal – 2 (6.8%), CNS – 2 (6.8%), SCV – 2 (6.8%), allergic history – 2 (6), 8%). Treatment for sensitive TB given in 10% of cases. Therapeutic result: cure 5 (17.2%), treatment completed 11 (37.95%), treatment continued 13 (44.8%). Conclusion. Adequate treatment of children with TB DR with a WHO-recommended regimen is an important step in ensuring a successful outcome of treatment, as well as in preventing the acquisition of additional drug resistance. |
||||||
Cuvinte-cheie Drug-resistant tuberculosis, children, tuberculoza drogrezistentă, copii |
||||||
|